top of page

Protagonist Therapeutics' CEO on its hepcidin memetic at #ASH23 and oral IL23 program in I&I

Dinesh Patel describes the science behind Protagonist's polycythemia vera program and how the company is developing oral peptides, starting with IL23.



Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page